Home 5 G2 Lab and Pathology Insider 5 archive 5 Trovagene Develops Urine-Based Liquid Biopsy Test for Lung Cancer Patients

Trovagene Develops Urine-Based Liquid Biopsy Test for Lung Cancer Patients

By Ron Shinkman, Editor, Laboratory Industry Report San Diego-based genomic laboratory Trovagene is developing an unconventional approach to liquid biopsies for lung cancer patients, relying on specimens of urine rather than blood. According to Trovagene’s research, it is able to track the DNA of circulating tumors through urine samples in patients with lung cancer. The […]

By Ron Shinkman, Editor, Laboratory Industry Report San Diego-based genomic laboratory Trovagene is developing an unconventional approach to liquid biopsies for lung cancer patients, relying on specimens of urine rather than blood. According to Trovagene’s research, it is able to track the DNA of circulating tumors through urine samples in patients with lung cancer. The…

This content is for Paid Members only.
Login Join Now

Related Posts